Amifostine Injections

Amifostine Injections Specification

Dosage Form
Injection

Salt Composition
Amifostine 500 mg

Indication
Cytoprotective agent to reduce the risk of nephrotoxicity with cisplatin and reduce xerostomia after radiotherapy

Origin
Pharmaceutical

Ingredients
Amifostine trihydrate, suitable excipients

Application
IV administration in oncology settings

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light

Shelf Life
2 years from the date of manufacture

Route of Administration
Intravenous

Prescription/Non prescription
Prescription only

Pack Size
Vial of 500 mg for reconstitution

Brand Name
Amifostine Injection

Compatibility
Compatible with 0.9% sodium chloride for reconstitution

Amifostine Injections Trade Information

Supply Ability
100 Packs Per Week

Delivery Time
1 Week

About Amifostine Injections

Amifostine:-

Article Related Diseases

    Smaller
    Medium
    Larger

    1
    2
    3
    4
    Next

Disclaimer:
Cytarabine - injection, Cytosar-U, Tarabine PFS
Take the Chronic Fatigue Syndrome Quiz
Take the Chronic Fatigue Quiz Take the Chronic Fatigue Quiz
Surprising Benefits of Sex Slideshow Surprising Benefits of Sex Slideshow
Foods & Drinks That Make You Gotta Go Slideshow Foods & Drinks That Make You Gotta Go Slideshow Pictures

GENERIC NAME: CYTARABINE - INJECTION (sye-TAIR-uh-bean)
BRAND NAME(S): Cytosar-U, Tarabine PFS

Warning | Medication Uses | How To Use | Side Effects | Precautions | Drug Interactions | Overdose | Notes | Missed Dose | Storage

WARNING: This medication may cause serious (rarely fatal) blood disorders (bone marrow suppression leading to anemia, low number of white blood cells and platelets). Liver problems may also occur. Your doctor will monitor you closely for these side effects.

Tell your doctor immediately if you develop any signs of infection (e.g., fever, chills, persistent sore throat), unusual fatigue, easy bruising or bleeding, nausea, vomiting, diarrhea, stomach/abdominal pain, dark urine, yellowing eyes/skin, or mouth sores.

Cytoprotective Support in Oncology

Amifostine Injection acts as a proven cytoprotective agent in oncology settings, providing essential protection against certain chemotherapy and radiotherapy side effects. This intravenous medication is commonly used to decrease the risk of kidney damage from cisplatin and to alleviate post-radiation xerostomia in head and neck cancer patients.

Easy Reconstitution and Administration

Designed for hospital use, Amifostine Injection is supplied as a 500 mg vial to be reconstituted with 0.9% sodium chloride. The solution is administered intravenously under medical supervision, ensuring patient safety and optimal therapeutic impact during cancer treatment regimens.

Safe Storage and Reliable Shelf Life

With storage instructions below 25C and protection from light, Amifostine Injection remains stable for up to two years from the date of manufacture. Its odorless formulation ensures comfort in preparation and administration within medical facilities.

FAQs of Amifostine Injections:

Q: How is Amifostine Injection prepared and administered?

A: Amifostine Injection should be reconstituted using 0.9% sodium chloride. The prepared solution is administered intravenously under the supervision of a healthcare professional, typically prior to chemotherapy or radiotherapy sessions.

Q: What is the main benefit of using Amifostine Injection during cancer treatment?

A: The primary benefit of Amifostine Injection is its cytoprotective effectit helps reduce the risk of nephrotoxicity during cisplatin therapy and minimizes xerostomia in patients receiving radiotherapy for head and neck cancer, improving overall treatment outcomes.

Q: When should Amifostine Injection be given to a patient?

A: This medication is administered just before chemotherapy (like cisplatin) or radiotherapy, following a schedule determined by the oncology team. The timing optimizes its protective effects against treatment-induced side effects.

Q: What steps are involved in the reconstitution process for Amifostine Injection?

A: First, the vial containing 500 mg Amifostine must be dissolved in an appropriate volume of 0.9% sodium chloride to create a clear solution. The reconstituted solution is then used for intravenous administration as directed by a healthcare provider.

Q: Where should Amifostine Injection be stored before use?

A: The vial should be stored in a cool place below 25C, away from direct light, to maintain its stability and effectiveness throughout its shelf life.

Q: Is Amifostine Injection available without a prescription?

A: No, Amifostine Injection is a prescription-only medicine. It should only be used under the guidance of qualified medical professionals in healthcare settings.